STERIS plc (STE) - Total Assets

Latest as of December 2025: $10.59 Billion USD

Based on the latest financial reports, STERIS plc (STE) holds total assets worth $10.59 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

STERIS plc - Total Assets Trend (1991–2025)

This chart illustrates how STERIS plc's total assets have evolved over time, based on quarterly financial data. Also see STE company net worth for the company's overall valuation and market capitalisation.

STERIS plc - Asset Composition Analysis

Current Asset Composition (March 2025)

STERIS plc's total assets of $10.59 Billion consist of 19.7% current assets and 80.3% non-current assets. Review STE liabilities breakdown to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $171.70 Million 1.7%
Accounts Receivable $1.04 Billion 10.3%
Inventory $581.33 Million 5.7%
Property, Plant & Equipment $2.11 Billion 20.8%
Intangible Assets $1.85 Billion 18.3%
Goodwill $4.10 Billion 40.4%

Asset Composition Trend (1991–2025)

This chart illustrates how STERIS plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See STERIS plc stock price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: STERIS plc's current assets represent 19.7% of total assets in 2025, a decrease from 81.8% in 1991.
  • Cash Position: Cash and equivalents constituted 1.7% of total assets in 2025, down from 6.8% in 1991.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, an increase from 6.0% in 1991.
  • Asset Diversification: The largest asset category is goodwill at 40.4% of total assets.

STERIS plc Competitors by Total Assets

Key competitors of STERIS plc based on total assets are shown below.

Company Country Total Assets
SS Innovations International Inc. Common Stock
NASDAQ:SSII
USA $96.98 Million
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
Germany €2.83 Billion
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
USA $1.81 Billion
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
Eurobio Scientific SA
PA:ALERS
France €259.11 Million
Profound Medical Corp
TO:PRN
Canada CA$62.28 Million
EBR Systems Inc
AU:EBR
Australia AU$97.29 Million

STERIS plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.48 2.13 2.10
Quick Ratio 1.75 1.40 1.55
Cash Ratio 0.46 0.17 0.00
Working Capital $1.36 Billion $1.01 Billion $633.83 Million

STERIS plc - Advanced Valuation Insights

This section examines the relationship between STERIS plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.84
Latest Market Cap to Assets Ratio 2.01
Asset Growth Rate (YoY) -8.3%
Total Assets $10.15 Billion
Market Capitalization $20.36 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values STERIS plc's assets at a significant premium (2.01x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: STERIS plc's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for STERIS plc (1991–2025)

The table below shows the annual total assets of STERIS plc from 1991 to 2025.

Year Total Assets Change
2025-03-31 $10.15 Billion -8.29%
2024-03-31 $11.06 Billion +2.23%
2023-03-31 $10.82 Billion -5.27%
2022-03-31 $11.42 Billion +73.76%
2021-03-31 $6.57 Billion +21.18%
2020-03-31 $5.43 Billion +6.95%
2019-03-31 $5.07 Billion -2.45%
2018-03-31 $5.20 Billion +5.60%
2017-03-31 $4.92 Billion -7.89%
2016-03-31 $5.35 Billion +154.66%
2015-03-31 $2.10 Billion +11.25%
2014-03-31 $1.89 Billion +7.16%
2013-03-31 $1.76 Billion +25.28%
2012-03-31 $1.41 Billion -1.47%
2011-03-31 $1.43 Billion +15.20%
2010-03-31 $1.24 Billion +1.76%
2009-03-31 $1.22 Billion -1.80%
2008-03-31 $1.24 Billion +2.49%
2007-03-31 $1.21 Billion +1.70%
2006-03-31 $1.19 Billion +0.27%
2005-03-31 $1.19 Billion +11.00%
2004-03-31 $1.07 Billion +19.35%
2003-03-31 $894.99 Million +6.35%
2002-03-31 $841.57 Million -0.40%
2001-03-31 $844.98 Million -6.48%
2000-03-31 $903.57 Million +4.34%
1999-03-31 $866.00 Million +18.25%
1998-03-31 $732.33 Million +35.74%
1997-03-31 $539.50 Million -8.98%
1996-03-31 $592.70 Million +979.60%
1995-03-31 $54.90 Million +28.57%
1994-03-31 $42.70 Million +38.19%
1993-03-31 $30.90 Million +286.25%
1992-03-31 $8.00 Million +81.82%
1991-03-31 $4.40 Million --

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$20.48 Billion
Market Cap Rank
#1268 Global
#526 in USA
Share Price
$208.79
Change (1 day)
+0.88%
52-Week Range
$199.40 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more